The author is in the Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas 77030, USA. crooney@bcm.edu
A new approach to tumor therapy combines two problematic cancer-fighting tools: tumor-targeted T cells and gene therapy. The T cells deliver a gene therapy vector to tumor cells, ensuring their destruction (pages 1073−1081).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
